MedPath

A Randomized Controlled Trial of Comparative Efficacy between Sodium Bicarbonate and Heparin as A Locking Solution for Tunneled Central Venous Catheters Among Patients Requiring Maintenance Hemodialysis

Phase 3
Conditions
Catheter loss due to CRT or CRBSI
Catheter lock
Catheter related blood stream infection
Catheter related thrombosis
End stage renal disease
Sodium bicarbonate
Heparin
Registration Number
TCTR20200610003
Lead Sponsor
Grant for research, Faculty of medicine, Chulalongkorn university
Brief Summary

The present study was stopped early due to an excess of catheter related thrombosis in the sodium bicarbonate group. From the first 6 weeks of follow-up, there were no catheter losses due to CRT or CRBSI in both groups. The sodium bicarbonate group had a significantly higher rate of the secondary composite outcomes and this was entirely caused by CRT with the median time to thrombosis of 23.6 days.

Detailed Description

Not available

Recruitment & Eligibility

Status
Terminated (Halted Prematurely)
Sex
All
Target Recruitment
118
Inclusion Criteria

1. Patients age more than 18 years old
2. Patients with maintenance chronic hemodialysis at least 2 sessions per week
3. Patients with permanent catheter as vascular access for hemodialysis

Exclusion Criteria

1. Catheter dysfunction at baseline
2. On current anticoagulation therapy
3. Patients with known coagulopathy or hemophilia
4. Patients with cirrhosis Child-Pugh B or C
5. Patients with thrombocytopenia less than 100,000 u/L
6. Patients with central vessel stenosis and vena cava syndrome, previously documented.
7. Patients with heparin-induced thrombocytopenia
8. Patients with unstable condition within 1 month before enrollment
9. Patients with expected life expectancy less than 6 month

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Catheter loss rate due to CRBSI and CRT 0, 3, 6 months record events per 6 months
Secondary Outcome Measures
NameTimeMethod
Composite outcome of CRT, CRBSI, or ESI/TI rate 0, 3, 6 month percentage
© Copyright 2025. All Rights Reserved by MedPath